| Title : Pinocembrin activation of DPP9 inhibits NLRP1 inflammasome activation to alleviate cerebral ischemia\/reperfusion-induced lung and intestinal injury - Wang_2024_Immunol.Res_73_13 |
| Author(s) : Wang P , Pan L , Liu Q , Huang Y , Tang Y , Lin B , Liao Y , Luo H , Meng X |
| Ref : Immunol Res , 73 :13 , 2024 |
|
Abstract :
After stroke, there is a high incidence of acute lung injury and impairment of intestinal barrier function. In this research, the effects of pinocembrin on organ injuries induced by cerebral ischemia-reperfusion were investigated in mice with middle cerebral artery occlusion/reperfusion (MCAO/R) and further explored the possible mechanism. The potential targets of pinocembrin against MCAO/R were obtained by online tools. An MCAO/R model was developed in C57BL/6 J mice, in combination with pinocembrin administration and lentivirus-mediated gene intervention. Pinocembrin alleviated neurological impairment, reduced the volume of cerebral infarction, attenuated pathological injury of brain tissues in MCAO/R-induced mice by promoting the expression of dipeptidyl peptidase 9 (DPP9), and blocked the nucleotide-binding domain leucine-rich repeat pyrin domain containing 1 (NLRP1) inflammasome activation. Moreover, pinocembrin attenuated the infiltration of inflammatory cells in the lungs and intestinal histopathological injury induced by MCAO/R. The above effects of pinocembrin were reversed by knocking down DPP9. These findings indicated that pinocembrin inhibits NLRP1 inflammasome activation by inducing DPP9, thus mitigating brain, lung, and intestinal injuries induced by MCAO/R. |
| PubMedSearch : Wang_2024_Immunol.Res_73_13 |
| PubMedID: 39676095 |
| Gene_locus related to this paper: human-DPP9 |
| Gene_locus | human-DPP9 |
Wang P, Pan L, Liu Q, Huang Y, Tang Y, Lin B, Liao Y, Luo H, Meng X (2024)
Pinocembrin activation of DPP9 inhibits NLRP1 inflammasome activation to alleviate cerebral ischemia\/reperfusion-induced lung and intestinal injury
Immunol Res
73 :13
Wang P, Pan L, Liu Q, Huang Y, Tang Y, Lin B, Liao Y, Luo H, Meng X (2024)
Immunol Res
73 :13